抗体

PD1中和小鼠单克隆抗体[3A11](EM1701-17)

EM1701-17

单克隆

3A11

单克隆

小鼠

未共轭

3A11

酶联免疫吸附测定, 流式细胞仪

PD1中和小鼠单克隆抗体[3A11](EM1701-17)

Mouse monoclonal primary

未共轭

单克隆

3A11

小鼠

酶联免疫吸附测定, FC

ELISA: 1:1, 000-1:5, 000;FC: 1:50-1:100

人类

重组蛋白

IgG1

PD1中和

Q15116

PD-1 blockade works during the effector phase to restore the immune function of T cells in the periphery that have been turned off following extended or high levels of antigen exposure, as in advanced cancer. The ligands for PD-1 can be expressed by tumor cells as well as tumor-infiltrating immune cells. PD-L1 expression on tumor cells varies by tumor type and also within a given tumor type, but appears to be particularly abundant in melanoma, non–small cell lung cancer (NSCLC), and ovarian cancer. In a recent study, PD-L1 expression on tumor cells was shown to be significantly associated with PD-1 expression on TILs, and was locally associated with PD-L2 expression when this ligand was also expressed. In the same study, tumor PD-L1 expression was the single factor most closely correlated with response to anti-PD-1 blockade, whereas PD-L1 expression on TILs was not associated with response. patient response to anti-PD-L1 blockade was strongest when PD-L1 was expressed by tumor-infiltrating immune cells. This antibody recognizing the PD-L1 binding region of PD1.

液体

蛋白质G亲和纯化

2微克/微升

1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.

Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.

32 kDa

HUABIO

100ul

325

2020&prior